A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers
Latest Information Update: 07 Nov 2021
At a glance
- Drugs HP 802247 (Primary)
- Indications Varicose ulcer
- Focus Registrational; Therapeutic Use
- 04 Dec 2014 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov record.
- 13 Oct 2014 Top-line results published in media release.
- 13 Oct 2014 Primary endpoint (Wound Closure - Improvement in wound healing over placebo) has not been met, according to the Smith and Nephew media release